Risk of infections in patients with gout: a population-based cohort study

Abstract To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research D...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: B. Spaetgens, F. de Vries, J. H. M. Driessen, H. G. Leufkens, P. C. Souverein, A. Boonen, J. W. M. van der Meer, L. A. B. Joosten
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/64a0bd9de8ec464d91a90a6c58524434
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:64a0bd9de8ec464d91a90a6c58524434
record_format dspace
spelling oai:doaj.org-article:64a0bd9de8ec464d91a90a6c585244342021-12-02T16:08:00ZRisk of infections in patients with gout: a population-based cohort study10.1038/s41598-017-01588-52045-2322https://doaj.org/article/64a0bd9de8ec464d91a90a6c585244342017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01588-5https://doaj.org/toc/2045-2322Abstract To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD). All patients with a first diagnosis of gout and aged >40 years between January 1987-July 2014, were included and matched with up to two controls. Time-varying Cox proportional hazards models were used to estimate the risk of infections and mortality. 131,565 patients and 252,763 controls (mean age: 64 years, 74% males, mean follow-up of 6.7 years) were included in the full cohort. After full statistical adjustment, the risk of pneumonia was increased (adj. HR 1.27, 95% CI 1.18 to 1.36), while the risk of UTI (adj. HR 0.99, 95% CI 0.97 to 1.01) was similar in patients compared to controls. No differences between patients and controls were observed for infection-related mortality due to pneumonia (adj. HR 1.03, 95% CI 0.93 to 1.14) or UTI (adj. HR 1.16, 95% CI 0.98 to 1.37). In conclusion, patients with gout did not have decreased risks of pneumonia, UTI or infection-related mortality compared to population-based controls.B. SpaetgensF. de VriesJ. H. M. DriessenH. G. LeufkensP. C. SouvereinA. BoonenJ. W. M. van der MeerL. A. B. JoostenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
B. Spaetgens
F. de Vries
J. H. M. Driessen
H. G. Leufkens
P. C. Souverein
A. Boonen
J. W. M. van der Meer
L. A. B. Joosten
Risk of infections in patients with gout: a population-based cohort study
description Abstract To investigate the risk of various types of infections (pneumonia and urinary tract infection (UTI)), and infection-related mortality in patients with gout compared with population-based controls. A retrospective cohort study was conducted using data from the UK Clinical Practice Research Datalink (CPRD). All patients with a first diagnosis of gout and aged >40 years between January 1987-July 2014, were included and matched with up to two controls. Time-varying Cox proportional hazards models were used to estimate the risk of infections and mortality. 131,565 patients and 252,763 controls (mean age: 64 years, 74% males, mean follow-up of 6.7 years) were included in the full cohort. After full statistical adjustment, the risk of pneumonia was increased (adj. HR 1.27, 95% CI 1.18 to 1.36), while the risk of UTI (adj. HR 0.99, 95% CI 0.97 to 1.01) was similar in patients compared to controls. No differences between patients and controls were observed for infection-related mortality due to pneumonia (adj. HR 1.03, 95% CI 0.93 to 1.14) or UTI (adj. HR 1.16, 95% CI 0.98 to 1.37). In conclusion, patients with gout did not have decreased risks of pneumonia, UTI or infection-related mortality compared to population-based controls.
format article
author B. Spaetgens
F. de Vries
J. H. M. Driessen
H. G. Leufkens
P. C. Souverein
A. Boonen
J. W. M. van der Meer
L. A. B. Joosten
author_facet B. Spaetgens
F. de Vries
J. H. M. Driessen
H. G. Leufkens
P. C. Souverein
A. Boonen
J. W. M. van der Meer
L. A. B. Joosten
author_sort B. Spaetgens
title Risk of infections in patients with gout: a population-based cohort study
title_short Risk of infections in patients with gout: a population-based cohort study
title_full Risk of infections in patients with gout: a population-based cohort study
title_fullStr Risk of infections in patients with gout: a population-based cohort study
title_full_unstemmed Risk of infections in patients with gout: a population-based cohort study
title_sort risk of infections in patients with gout: a population-based cohort study
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/64a0bd9de8ec464d91a90a6c58524434
work_keys_str_mv AT bspaetgens riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT fdevries riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT jhmdriessen riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT hgleufkens riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT pcsouverein riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT aboonen riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT jwmvandermeer riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
AT labjoosten riskofinfectionsinpatientswithgoutapopulationbasedcohortstudy
_version_ 1718384659805503488